Chiriac, U.; Richter, D.; Frey, O.R.; Röhr, A.C.; Helbig, S.; Hagel, S.; Liebchen, U.; Weigand, M.A.; Brinkmann, A.
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients. Antibiotics 2023, 12, 1112.
https://doi.org/10.3390/antibiotics12071112
AMA Style
Chiriac U, Richter D, Frey OR, Röhr AC, Helbig S, Hagel S, Liebchen U, Weigand MA, Brinkmann A.
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients. Antibiotics. 2023; 12(7):1112.
https://doi.org/10.3390/antibiotics12071112
Chicago/Turabian Style
Chiriac, Ute, Daniel Richter, Otto R. Frey, Anka C. Röhr, Sophia Helbig, Stefan Hagel, Uwe Liebchen, Markus A. Weigand, and Alexander Brinkmann.
2023. "Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients" Antibiotics 12, no. 7: 1112.
https://doi.org/10.3390/antibiotics12071112
APA Style
Chiriac, U., Richter, D., Frey, O. R., Röhr, A. C., Helbig, S., Hagel, S., Liebchen, U., Weigand, M. A., & Brinkmann, A.
(2023). Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients. Antibiotics, 12(7), 1112.
https://doi.org/10.3390/antibiotics12071112